Lipocalin family protein
CA 2375386 A1 · Owner: Incyte Genomics, Inc. · Inventors: Baughn, Mariah R.; Murry, Lynn E.; Tang, Y. Tom
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a mammalian nucleic acid molecule and fragments thereof encoding a lipocalin. It also provides for the use of the mammalian nucleic acid molecule for the characterization diagnosis, evaluation, treatment, or , prevention of conditions diseases and disorders associated with gene expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid molecule.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 9, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 9, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 9, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.